Tender card #8/2020
Zákazka na veľa častí

Information

ID of tender: 5483
Name of content of tender: Zákazka na veľa častí
Tender ref. no.: 8/2020
Public tender journal ref. no.: 158/2020, dňa 02.06.2020, 33333-MST
EU journal ref. no.: 2020/S 218-195875
Type of tender: Nadlimitná zákazka
Type of public tender: Verejná súťaž podľa § 66 (7)
Type of procurement: Goods
Estimated value: 238 561,1400 EUR
Main CPV: 33690000-3 - Various medicinal products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
33692100-8 - Infusion solutions
Tender split into parts: Yes
Centralised tender: No
NUTS: SK - Slovenská republika
Brief description of tender or procurement: uvedený v súťažných podkladoch
For evaluation the price is determined: including VAT

Schedule

Lehota na predkladanie ponúk: 03.06.2020 09:45:00
Planned opening of bids: 03.06.2020 10:00:00

Public Promoter

Subject's name: ********
Address: ********
Process supervisor: ********

Documents

Name of document	Type	Size	Uploaded on
Oprava súťažných podkladov - 2	Súťažné podklady	21.5 KB	03.06.2020 09:05:25
Oprava súťažných podkladov - 1	Súťažné podklady	21.5 KB	03.06.2020 08:01:30
Vysvetlenie súťažných podkladov - 1	Súťažné podklady	21.5 KB	02.06.2020 12:45:43
Súťažné podklady s prílohami	Súťažné podklady	21.5 KB	02.06.2020 10:40:21

Časť 1: Doxorubicin

Status: Ongoing
Predicted value not including VAT: 6 605,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 2: Etoposidum

Status: Ongoing
Predicted value not including VAT: 9 927,1200 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 3: Epirubicin

Status: Ongoing
Predicted value not including VAT: 17 016,1000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 4: Oxaliplatina

Status: Ongoing
Predicted value not including VAT: 24 400,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 5: Topotecan

Status: Ongoing
Predicted value not including VAT: 6 053,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 6: Gemcitabin

Status: Ongoing
Predicted value not including VAT: 26 097,7800 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 7: Irinotecan

Status: Ongoing
Predicted value not including VAT: 48 521,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 8: Docetaxel

Status: Ongoing
Predicted value not including VAT: 21 093,1400 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 9: Paclitaxel

Status: Ongoing
Predicted value not including VAT: 45 190,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 10: Vinorelbin

Status: Ongoing
Predicted value not including VAT: 12 714,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement

Časť 11: Bleomycin

Status: Ongoing
Predicted value not including VAT: 20 944,0000 EUR
Criterion for evaluation of bid: Lowest price
Electronic auction: Yes
Main CPV: 33600000-6 - Pharmaceutical products
Further CPV: 33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender: Framework Agreement